Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy Results expected Sep 2026 (estimated)
- Wrist vs groin: which artery route is best for stroke clot removal? Results expected Sep 2026 (estimated)
- New rad combo targets kidney cancer after immunotherapy fails Results expected Sep 2026 (estimated)
- Could a common bile acid pill shield kidneys during cancer surgery? Results expected Oct 2026 (estimated)
- New hope for liver cancer patients: 4-drug combo targets untreatable tumors Results expected Nov 2026 (estimated)
-
Can a new PET tracer spot tumors more clearly?
Diagnosis CancelledThis trial tests whether an experimental imaging agent, 18F-LNC1007, can improve the detection, staging, and recurrence monitoring of tumors compared to the standard 18F-FDG PET/CT scan. Adults with suspected or confirmed tumors will receive both types of scans within a week, and…
Sponsor: Jinling Hospital, China • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
AI reads heart scans to predict heart attacks
Diagnosis By invitation onlyThis study is developing an artificial intelligence system to analyze CT scans of the heart. The goal is to automatically detect and measure dangerous plaque that can cause heart attacks. Researchers will compare the AI's findings with detailed imaging tests and track patient out…
Sponsor: Jinling Hospital, China • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC